PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-60.51%
Both yoy net incomes decline, with CNQ at -62.43%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.78%
Some D&A expansion while CNQ is negative at -24.26%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-47.06%
Negative yoy deferred tax while CNQ stands at 111.49%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
9.52%
Less SBC growth vs. CNQ's 415.79%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-408.26%
Both reduce yoy usage, with CNQ at -102.67%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
104.76%
AR growth of 104.76% while CNQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-774.16%
Both reduce yoy usage, with CNQ at -102.67%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
69.22%
Lower 'other non-cash' growth vs. CNQ's 957.21%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-49.79%
Both yoy CFO lines are negative, with CNQ at -40.44%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
5.65%
Some CapEx rise while CNQ is negative at -14.15%. John Neff would see competitor possibly building capacity while we hold back expansions.
-378.04%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
103.72%
We have some outflow growth while CNQ is negative at -1062.07%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-5.08%
Both yoy lines negative, with CNQ at -47.15%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-1.20%
We cut debt repayment yoy while CNQ is 86.99%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-371.70%
We cut yoy buybacks while CNQ is 60.88%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.